What's in Alimentiv Inc.'s pipeline?

Alimentiv Inc. has 4 drugs in our index: 4 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Alimentiv Inc.'s portfolio?

Top competitors by shared drug class: Caja Costarricense de Seguro Social, Chong Kun Dang Pharmaceutical, Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives, Janssen Pharmaceutical K.K., Second Affiliated Hospital, School of Medicine, Zhejiang University.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/alimentiv-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Alimentiv Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Alimentiv Inc. pipeline: 4 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

4 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Treatment Algorithm C	Treatment Algorithm C	marketed
Treatment Algorithm A	Treatment Algorithm A	marketed			Gastroenterology
Treatment Algorithm B	Treatment Algorithm B	marketed			Gastroenterology
Mirikizumab (MIR)	Mirikizumab (MIR)	marketed	IL-23 inhibitor monoclonal antibody	IL-23 p19 subunit	Immunology / Gastroenterology

Therapeutic area mix

Gastroenterology · 2
Immunology / Gastroenterology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Caja Costarricense de Seguro Social · 1 shared drug class
Chong Kun Dang Pharmaceutical · 1 shared drug class
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives · 1 shared drug class
Janssen Pharmaceutical K.K. · 1 shared drug class
Second Affiliated Hospital, School of Medicine, Zhejiang University · 1 shared drug class
Sun Pharmaceutical Industries Limited · 1 shared drug class
University of Calgary · 1 shared drug class
University of North Carolina, Chapel Hill · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Alimentiv Inc.:

Cite this brief

Drug Landscape (2026). Alimentiv Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/alimentiv-inc. Accessed 2026-06-10.